Dow Up 1.31% Nasdaq Up 2.40%

Trevena, Inc. (TRVN)

-NasdaqGS
5.04 Down 0.12(2.33%) Oct 21, 4:00PM EDT
Prev Close:5.16
Open:5.10
Bid:N/A
Ask:23.90 x 4400
1y Target Est:14.33
Beta:N/A
Next Earnings Date:11-Nov-14TRVN Earnings announcement
Day's Range:4.92 - 5.34
52wk Range:4.01 - 9.95
Volume:16,970
Avg Vol (3m):60,012
Market Cap:132.85M
P/E (ttm):N/A
EPS (ttm):-3.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TRVN

Comparison

Symbol% ChgMkt Cap
TRVNDown 2.33%132.85M
CYTKDown 1.73%124.83M
NVSUp 0.81%214.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.93
Quarterly EPS Est (Sep-14) :-0.45
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback